drugset
drugset / Trial / NCT04351347

The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment

NCT04351347 ↗

Phase 2/3 Recruiting 300 enrolled Tanta University
RandomizedParallel-groupOpen-labelTreatment

Summary

Efficacy of Ivermectin in larger doses in COVID-19 treatment

Timeline

Start
2020-06-16
Primary completion
2030-12-01
Completion
2030-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ivermectin Small molecule — —

Indications

COVID-19